CHRONIC INDUCIBLE URTICARIA
Clinical trials for CHRONIC INDUCIBLE URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INDUCIBLE URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC INDUCIBLE URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may stop hives from cold and scratching in their tracks
Disease control Recruiting nowThis study tests a new medicine called barzolvolimab for people who get hives from cold temperatures or from scratching their skin. About 240 adults who still have symptoms despite taking allergy pills will receive either the study drug or a placebo. The goal is to see if the dru…
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New injection could calm stubborn hives
Symptom relief Recruiting nowThis early-stage study tests a single dose of a new drug, GTX-B001, for safety. First, healthy volunteers receive the drug to check for side effects. Then, people with chronic inducible urticaria (hives triggered by cold or pressure) receive it to see if it helps. The goal is to …
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE1 • Sponsor: Granular Therapeutics Limited • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New pill could stop stubborn hives when allergy meds fail
Symptom relief Recruiting nowThis study tests an experimental drug called BLU-808 for people with chronic hives (either triggered by heat, cold, or pressure, or happening for no clear reason) that don't get better with standard allergy pills. The goal is to see if the drug is safe and can reduce hives sympto…
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
New pill for chronic hives enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study tests an experimental pill called EDP-978 in healthy adults to see if it is safe and how the body handles it. The drug is being developed for people with long-lasting hives. About 98 participants will receive either the drug or a placebo, and researchers wi…
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE1 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC